scholarly journals Neoadjuvant hormonal therapy for low-risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis-related parameters

The Prostate ◽  
2017 ◽  
Vol 77 (14) ◽  
pp. 1408-1415 ◽  
Author(s):  
Yasuyoshi Miyata ◽  
Yuichiro Nakamura ◽  
Takuji Yasuda ◽  
Tomohiro Matsuo ◽  
Kojiro Ohba ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Hormonal Therapy ◽  
Biochemical Recurrence ◽  
Low Risk ◽  
Neoadjuvant Hormonal Therapy ◽  
Risk Prostate Cancer ◽  
Low Risk Prostate Cancer

339 EARLY BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY DOES NOT ALTER SURVIVAL IN MEN WITH LOW RISK PROSTATE CANCER

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Anthony Ta ◽  
Damien Bolton ◽  
Graham Giles ◽  
Gianluca Severi ◽  
Melisa Bagnato ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Biochemical Recurrence ◽  
Low Risk ◽  
Risk Prostate Cancer ◽  
Low Risk Prostate Cancer

scholarly journals Assessment of PSIM (Prostatic Systemic Inflammatory Markers) Score in Predicting Pathologic Features at Robotic Radical Prostatectomy in Patients with Low-Risk Prostate Cancer Who Met the Inclusion Criteria for Active Surveillance

Diagnostics ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 355
Author(s):  
Matteo Ferro ◽  
Gennaro Musi ◽  
Deliu Victor Matei ◽  
Alessandro Francesco Mistretta ◽  
Stefano Luzzago ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Active Surveillance ◽  
Inflammatory Markers ◽  
Low Risk ◽  
Inclusion Criteria ◽  
Robotic Radical Prostatectomy ◽  
Lymphocyte Ratio ◽  
Risk Prostate Cancer ◽  
Low Risk Prostate Cancer

Background: circulating levels of lymphocytes, platelets and neutrophils have been identified as factors related to unfavorable clinical outcome for many solid tumors. The aim of this cohort study is to evaluate and validate the use of the Prostatic Systemic Inflammatory Markers (PSIM) score in predicting and improving the detection of clinically significant prostate cancer (csPCa) in men undergoing robotic radical prostatectomy for low-risk prostate cancer who met the inclusion criteria for active surveillance. Methods: we reviewed the medical records of 260 patients who fulfilled the inclusion criteria for active surveillance. We performed a head-to-head comparison between the histological findings of specimens after radical prostatectomy (RP) and prostate biopsies. The PSIM score was calculated on the basis of positivity according to cutoffs (neutrophil-to-lymphocyte ratio (NLR) 2.0, platelets-to-lymphocyte ratio (PLR) 118 and monocyte-to-lymphocyte-ratio (MLR) 5.0), with 1 point assigned for each value exceeding the specified threshold and then summed, yielding a final score ranging from 0 to 3. Results: median NLR was 2.07, median PLR was 114.83, median MLR was 3.69. Conclusion: we found a significantly increase in the rate of pathological International Society of Urological Pathology (ISUP) ≥ 2 with the increase of PSIM. At the multivariate logistic regression analysis adjusted for age, prostate specific antigen (PSA), PSA density, prostate volume and PSIM, the latter was found the sole independent prognostic variable influencing probability of adverse pathology.

Does Race Affect Postoperative Outcomes in Patients With Low-Risk Prostate Cancer Who Undergo Radical Prostatectomy?

Urology ◽  
2009 ◽  
Vol 73 (3) ◽  
pp. 620-623 ◽  
Author(s):  
M.J. Resnick ◽  
D.J. Canter ◽  
T.J. Guzzo ◽  
B.M. Brucker ◽  
M. Bergey ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Low Risk ◽  
Postoperative Outcomes ◽  
Risk Prostate Cancer ◽  
Low Risk Prostate Cancer

Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy

2017 ◽  
Vol 35 (8) ◽  
pp. 1205-1212 ◽  
Author(s):  
Alexander Kretschmer ◽  
Alexander Buchner ◽  
Markus Grabbert ◽  
Anne Sommer ◽  
Annika Herlemann ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Patient Education ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Low Risk ◽  
Risk Prostate Cancer ◽  
Low Risk Prostate Cancer ◽  
Satisfaction Rates

Lifelong Yearly Prostate Specific Antigen Surveillance is Not Necessary for Low Risk Prostate Cancer Treated With Radical Prostatectomy

2010 ◽  
Vol 184 (3) ◽  
pp. 925-929 ◽  
Author(s):  
Matthew K. Tollefson ◽  
Michael L. Blute ◽  
Laureano J. Rangel ◽  
R. Jeffrey Karnes ◽  
Igor Frank
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Low Risk ◽  
Risk Prostate Cancer ◽  
Low Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document